查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2056578

合成生物學市場規模、佔有率、趨勢和預測：按產品、技術、應用和地區分類，2026-2034年

Synthetic Biology Market Size, Share, Trends and Forecast by Product, Technology, Application, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2025年全球合成生物學市場規模為214億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以14.09%的複合年成長率成長，到2034年達到724億美元。目前，北美市場佔據主導地位，預計2025年市佔率將超過41.8%。北美市場的主導地位歸功於其強大的生物技術基礎設施、不斷成長的研發投入以及政府的支持政策。

合成生物學市場分析：

主要市場促進因素：全球合成生物學市場正經歷強勁成長，這主要得益於基因編輯技術的穩定進步。

市場主要趨勢：學術界、產業界和政府之間的合作正在增強創新和發展能力。

區域趨勢：北美市場因生物技術投資增加而佔據主導地位。然而，亞太地區正憑藉著不斷成長的研究活動和政府舉措，迅速崛起為新興市場。

競爭格局：領導企業正加大研發投入，以推動創新並應對複雜的生物學挑戰。合成生物學產業的主要市場參與者包括金斯瑞生物技術公司（GenScript Biotech Corporation）、Amyris Inc.、Ginkgo Bioworks、Mammoth Biosciences、諾維信公司（Novozymes）和默克集團（Merck KGaA）。

挑戰與機會：挑戰包括與基因改造產品相關的倫理與安全議題。然而，開發符合監管規定且符合倫理道德的創新產品的市場機會有望克服這些挑戰。

合成生物學市場的趨勢與促進因素：

基因編輯技術的進步

目前，CRISPR-Cas9等多種技術能夠精準且有效率地操控遺傳物質，推動生物學研究領域的發展，並增強了合成生物學市場的需求。研究人員正以極高的精準度設計、編輯和修改DNA序列，以建構出功能各異的複雜合成生物體。這項創新為基因治療等新興領域的發展鋪平了道路，也為構建能夠生產酶和生質燃料等有用化合物的生物工程生物體提供了可能，進而促進了市場擴張。此外，世界衛生組織（WHO）發布了關於人類基因組編輯全球管治的開創性建議，強調了安全性、有效性和倫理性。

對永續解決方案的需求

各行各業對永續和環保解決方案日益成長的需求正在推動合成生物學市場的發展。合成生物學為各行業提供了多種新途徑，以滿足其減少業務活動對環境影響的需求。因此，利用可再生資源生產生質塑膠以及開發符合全球永續性的排放生質燃料，都在促進市場成長。此外，合成生物學還可以創造用於生物修復的微生物，這是一種中和污染物、幫助淨化環境的方法，從而應對各種緊迫的生態學挑戰。而且，合成生物學正在革新美容產業的永續發展。根據《Vogue Business》估計，每年有20%至40%的美容產品被廢棄物，該行業每年產生1200億件不可回收的包裝。此外，十分之八的化妝品成分並非永續採購。為了應對這些挑戰，合成生物學正在改造微生物的DNA以創造永續材料。合成生物學市場的價格反映了其由創新和多樣化應用驅動的快速成長。

協作生態系統與投資

學術界、產業界和政府機構之間的協同合作，正在為合成生物學領域的研究活動創造有利環境。這些合作促進了知識、資源和觀點的交流，從而加快了創新步伐。政府機構經常提供津貼和資金支持研究活動，而成熟企業和新創公司則透過合作共用資源，共同開展突破性項目，推動市場成長。此外，創業投資對生物技術新創企業的激增，為該領域注入了至關重要的資金，推動早期構想轉化為合成生物學市場中的具體產品和應用。這種合作生態系維繫著研究、創新和商業化的循環，推動著全球合成生物學市場的發展。

此外，合成生物學市場的未來前景廣闊，有望帶來前所未有的創新、永續性的解決方案以及巨大的成長潛力。像Algal Bio這樣的公司正在利用多種細菌菌株來創造新型解決方案，而像Basecamp Research這樣的新創公司則正在利用機器學習（ML）來揭示自然界的設計原理，並將其應用於合成蛋白質工程。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球合成生物學市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 寡核苷酸/寡核苷酸叢集和合成DNA
  • 酵素
  • 克隆技術套件
  • 異源核酸
  • 底盤生物

第7章 市場區隔：依技術分類

  • NGS技術
  • PCR技術
  • 基因組編輯技術
  • 生物製程技術
  • 其他

第8章 市場區隔：依應用領域分類

  • 衛生保健
    • 主要部分
      • 臨床階段
      • 非臨床/研究
  • 除了醫療保健之外
    • 主要部分
      • 生物技術作物
      • 特種化學品
      • 生質燃料
      • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Agilent Technologies Inc.
    • Amyris Inc.
    • Codexis Inc.
    • Danaher Corporation
    • Eurofins Scientific
    • GenScript Biotech Corporation
    • Illumina Inc.
    • Merck KGaA
    • New England Biolabs
    • Synthego Corporation
    • Thermo Fisher Scientific Inc.
    • Twist Bioscience
    • Viridos Inc.
Product Code: SR112026A5534

The global synthetic biology market size was valued at USD 21.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 72.4 Billion by 2034, exhibiting a CAGR of 14.09% from 2026-2034. North America currently dominates the market, holding a market share of over 41.8% in 2025. The dominance of North America can be attributed to robust biotechnology infrastructure, increasing investments in research operations, and supportive government initiatives.

Synthetic Biology Market Analysis:

Major Market Drivers: The global synthetic biology market is experiencing robust growth, driven by increasing improvements in gene editing technologies.

Key Market Trends: Collaborative efforts between academia, industry, and government are enhancing innovation and development capabilities.

Geographical Trends: North America dominates the market owing to the growing investments in biotechnology. However, Asia Pacific is emerging as a fast-growing market due to the increasing research activities and government initiatives in the region.

Competitive Landscape: Key players are investing in research operations to drive innovation and address complex biological challenges. Some of the major market players in the synthetic biology industry include GenScript Biotech Corporation, Amyris Inc., Ginkgo Bioworks, Mammoth Biosciences, Novozymes, Merck KGaA, among many others.

Challenges and Opportunities: Challenges include ethical and safety concerns related to genetically modified products. Nonetheless, opportunities for the market to develop regulatory-compliant, ethically considered innovations are projected to overcome these challenges.

Synthetic Biology Market Trends/Drivers:

Advancements in gene editing technologies

At present, various techniques like CRISPR-Cas9 are capable of improving the field of biology research by enabling precise and efficient manipulation of genetic material, strengthening the synthetic biology market demand. Researchers are designing, editing, and engineering DNA sequences with exceptional accuracy, facilitating the creation of intricate synthetic organisms customized according to specific functions. This innovation is opening new avenues for the development of novel aspects, like disease treatment through gene therapies and creation of bioengineered organisms capable of producing valuable compounds such as enzymes and biofuels, thus aiding in market expansion. Moreover, The World Health Organization (WHO) released groundbreaking recommendations for the global governance of human genome editing, emphasizing safety, efficacy, and ethics.

Demand for sustainable solutions

The rising demand for sustainable and environment-friendly solutions across various industries is propelling the synthetic biology market. Synthetic biology presents various new avenues for sectors to fulfill their demands to reduce the environmental impact of their operations. In line with this, the production of bioplastics extracted from renewable resources and the development of biofuels with reduced carbon emissions aligning with the global push towards sustainability are contributing to the market growth. Apart from this, synthetic biology is capable of creating microbes for bioremediation which is a method to detoxify contaminants or help clean up the environment and address various urgent ecological complications. Furthermore, synthetic biology is revolutionizing the sustainability efforts of the beauty sector. Vogue Business estimates that 20-40% of beauty products become waste annually, and the industry generates 120 billion units of difficult-to-recycle packaging yearly. Moreover, eight out of ten cosmetic ingredients are unsustainably sourced. To address these challenges, synthetic biology modifies microorganism DNA to create sustainable materials. The synthetic biology market price reflects rapid growth due to innovation and diverse applications.

Collaborative ecosystem and investment

The collaborative synergy between academia, industry, and government entities fosters a conducive environment for research operations within the synthetic biology field. Collaborations facilitate the exchange of knowledge, assets, and perspectives, thus quickening the rate of invention. Governing authorities frequently provide grants and funds to assist research endeavors, while established businesses and startups work together to pool resources for ground-breaking ventures that promote market growth. In addition to this, the surge in venture capital investments in biotechnology startups injects vital capital into the field, nurturing the growth of nascent ideas into tangible products and synthetic biology market application. This collaborative ecosystem sustains a cycle of research, innovation, and commercialization, propelling the global synthetic biology market forward.

Additionally, the future of the synthetic biology market promises unparalleled innovation, sustainability solutions, and expansive growth potential. Companies, such as Algal Bio utilize a diverse array of strains to innovate novel solutions, while startups like Basecamp Research employ machine learning (ML) to decipher the design principles of nature for synthetic protein engineering.

Synthetic Biology Industry Segmentation:

This report provides an analysis of the key trends in each segment of the global synthetic biology market, along with forecast at the global, regional, and country levels from 2026-2034. The market has been categorized based on product, technology, application.

Breakup by Product:

  • Oligonucleotide/Oligo Pools and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Xeno-nucleic Acids
  • Chassis Organism

Oligonucleotide/oligo pools and synthetic DNA dominates the market

The growing demand for synthetic biology products, specifically oligonucleotide/oligo pools and synthetic DNA, is mainly fueled by the exponential growth in fields such as personalized medicine, gene therapy, and molecular diagnostics that have amplified the need for precise and customizable genetic materials. Additionally, the rise of synthetic biology startups and the democratization of gene editing technologies have made these products more accessible, empowering researchers across diverse disciplines to engage in innovative projects, thereby creating a favorable synthetic biology market outlook. For example, Synbio Technologies offers oligo pool synthesis for companies or clients who need to mass-produce short DNA strands, also known as oligonucleotides.

Breakup by Technology:

  • NGS Technology
  • PCR Technology
  • Genome Editing Technology
  • Bioprocessing Technology
  • Others

Next-generation sequencing (NGS) technology has become instrumental in deciphering complex biological information, facilitating the analysis of vast genetic data sets, and accelerating the discovery of novel genetic components, which in turn, is presenting lucrative market opportunities. Moreover, polymerase chain reaction (PCR) technology remains a cornerstone for DNA amplification, crucial in generating sufficient genetic material for various applications, from research to diagnostics. Besides this, genome editing technologies, particularly CRISPR-Cas9, hold immense promise for precision genetic modifications, driving advancements in gene therapies and customized genetic engineering. Bioprocessing technologies form a critical facet, enabling efficient large-scale production of bioengineered compounds, ranging from pharmaceuticals to biofuels. Companies are also investing and focusing on these aspects to create novel technologies. For example, Bayer and Mammoth Biosciences collaborated to develop a novel gene editing technology to unlock the full potential of CRISPR systems.

Additionally, the synthetic biology market statistics highlight a robust growth trajectory, driven by advancements in biotechnology and increasing investment in research and development.

Breakup by Application:

  • Healthcare
  • Clinical
  • Non-Clinical/Research
  • Non-Healthcare
  • Biotech Crops
  • Specialty Chemicals
  • Bio-Fuels
  • Others

The bolstering growth of the healthcare sector, wherein synthetic biology is used in the development of personalized medicines, gene therapies, and diagnostics, is contributing to the synthetic biology market growth. In addition, the numerous non-clinical or research applications of synthetic biology encompassing drug discovery, functional genomics, and biomolecule production, are fueling scientific exploration and market growth. Beyond healthcare, synthetic biology's expanding usage in biotech crops engineered for improved yield and resistance to pests is positively influencing the market. Furthermore, the increasing product adoption across the specialty chemicals industry, wherein bioengineered pathways create sustainable routes to produce high-value compounds is impelling the market growth. Apart from this, the growing use of synthetic biology in the biofuel sector to optimize microorganisms for efficient biofuel production is strengthening the market growth. Key market players are focusing on collaborating with each other to develop various novel technologies in synthetic biology. For instance, scientists led by Gerard Wright at McMaster University developed a synthetic biology platform for novel glycopeptide antibiotics (GPA) discovery. They engineered Streptomyces coelicolor as a chassis for GPA biosynthesis, overcoming challenges in cloning large biosynthetic gene clusters (BGCs) using an optimized transformation-associated recombination (TAR) system. The platform enabled the synthesis of corbomycin and the discovery of novel GPAs, expanding antibiotic candidates' repertoire.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest synthetic biology market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The presence of a well-established research and innovation ecosystem in North America, characterized by leading academic institutions, cutting-edge biotechnology companies, and significant government investments, provides a fertile ground for advancements in synthetic biology. Moreover, the region's emphasis on R&D and technological innovation fosters collaborations that span academia and industry, driving the development of novel applications across sectors including healthcare, agriculture, and energy. In addition to this, the increasing focus on sustainable solutions and the demand for eco-friendly products align with synthetic biology's potential to offer greener alternatives. This, coupled with favorable regulatory frameworks that encourage biotechnology R&D, creates an environment conducive to the expansion of the North American synthetic biology market. In December 2022, the Investment Strategy by the Office of Strategic Capital (OSC) identifies synthetic biology as a priority technology area for private sector investment, aiming to attract capital and foster innovation in this field for national security purposes. The synthetic biology market overview reveals its rapid expansion, driven by innovation, research investment, and diverse applications.

Competitive Landscape:

The global synthetic biology market features a dynamic competitive landscape shaped by a blend of established players and innovative startups. Leading companies, with their significant financial resources and expansive research capabilities, dominate the market by offering a diverse range of synthetic biology products and services and highlighting how big is the synthetic biology market? These companies actively engage in collaborations, strategic partnerships, and mergers to enhance their offerings and expand their market reach. Furthermore, a surge in venture capital investments has catalyzed the emergence of agile startups, injecting fresh ideas and disruptive technologies into the field. The competitive arena is characterized by a focus on innovation, technology integration, and the ability to address diverse market segments, accentuating the evolutionary nature of the global synthetic biology market. On of the key players, Eurofins Genomics Blue Heron, introduced its IVT mRNA Synthesis Service, using cutting-edge technology for rapid and efficient mRNA transcript production. Tailored for various fields including molecular biology and gene therapy, it offers customizable synthesis with quick turnaround times and expert support, benefiting synthetic biology research and applications. According to synthetic biology market recent news, Aanika Biosciences is revolutionizing synthetic biology adoption across industries like food and agriculture through insurance. Their subsidiary, Aanika Insurance Services (AIS), offers cost-effective coverage, encouraging biologic use while ensuring risk mitigation and frequent sampling. Partnering with Western Growers Insurance Services, Aanika aims to expand its reach to farmers, distributors, and retailers.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Agilent Technologies Inc.
  • Amyris Inc.
  • Codexis Inc.
  • Danaher Corporation
  • Eurofins Scientific
  • GenScript Biotech Corporation
  • Illumina Inc.
  • Merck KGaA
  • New England Biolabs
  • Synthego Corporation
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience
  • Viridos Inc.

Key Questions Answered in This Report

1. What is synthetic biology?

2. How big is the synthetic biology market?

3. What is the expected growth rate of the global synthetic biology market during 2026-2034?

4. What are the key factors driving the global synthetic biology market?

5. What is the leading segment of the global synthetic biology market based on product?

6. What is the leading segment of the global synthetic biology market based on technology?

7. What is the leading segment of the global synthetic biology market based on application?

8. What are the key regions in the global synthetic biology market?

9. Who are the key players/companies in the global synthetic biology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Synthetic Biology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oligonucleotide/Oligo Pools and Synthetic DNA
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Enzymes
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cloning Technologies Kits
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Xeno-nucleic Acids
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Chassis Organism
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 NGS Technology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 PCR Technology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Genome Editing Technology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Bioprocessing Technology
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Healthcare
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Clinical
      • 8.1.2.2 Non-Clinical/Research
    • 8.1.3 Market Forecast
  • 8.2 Non-Healthcare
    • 8.2.1 Market Trends
    • 8.2.2 Key Segments
      • 8.2.2.1 Biotech Crops
      • 8.2.2.2 Specialty Chemicals
      • 8.2.2.3 Bio-Fuels
      • 8.2.2.4 Others
    • 8.2.3 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amyris Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Codexis Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Eurofins Scientific
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GenScript Biotech Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Illumina Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 New England Biolabs
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Synthego Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Twist Bioscience
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
    • 14.3.13 Viridos Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio

List of Figures

  • Figure 1: Global: Synthetic Biology Market: Major Drivers and Challenges
  • Figure 2: Global: Synthetic Biology Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Synthetic Biology Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Synthetic Biology Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Synthetic Biology Market: Breakup by Technology (in %), 2025
  • Figure 6: Global: Synthetic Biology Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Synthetic Biology Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Synthetic Biology (Oligonucleotide/Oligo Pools and Synthetic DNA) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Synthetic Biology (Oligonucleotide/Oligo Pools and Synthetic DNA) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Synthetic Biology (Enzymes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Synthetic Biology (Enzymes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Synthetic Biology (Cloning Technologies Kits) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Synthetic Biology (Cloning Technologies Kits) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Synthetic Biology (Xeno-nucleic Acids) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Synthetic Biology (Xeno-nucleic Acids) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Synthetic Biology (Chassis Organism) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Synthetic Biology (Chassis Organism) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Synthetic Biology (NGS Technology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Synthetic Biology (NGS Technology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Synthetic Biology (PCR Technology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Synthetic Biology (PCR Technology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Synthetic Biology (Genome Editing Technology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Synthetic Biology (Genome Editing Technology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Synthetic Biology (Bioprocessing Technology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Synthetic Biology (Bioprocessing Technology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Synthetic Biology (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Synthetic Biology (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Synthetic Biology (Healthcare) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Synthetic Biology (Healthcare) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Synthetic Biology (Non-Healthcare) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Synthetic Biology (Non-Healthcare) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: North America: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: North America: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: United States: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: United States: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Canada: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Canada: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Asia-Pacific: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Asia-Pacific: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: China: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: China: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Japan: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Japan: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: India: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: India: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: South Korea: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: South Korea: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Australia: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Australia: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Indonesia: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Indonesia: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Others: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Others: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Europe: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Europe: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Germany: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Germany: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: France: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: France: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: United Kingdom: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: United Kingdom: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Italy: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Italy: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Spain: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Spain: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Russia: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Russia: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Latin America: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Latin America: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Brazil: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Brazil: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Mexico: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Mexico: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Middle East and Africa: Synthetic Biology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Middle East and Africa: Synthetic Biology Market: Breakup by Country (in %), 2025
  • Figure 80: Middle East and Africa: Synthetic Biology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Global: Synthetic Biology Industry: SWOT Analysis
  • Figure 82: Global: Synthetic Biology Industry: Value Chain Analysis
  • Figure 83: Global: Synthetic Biology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Synthetic Biology Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Synthetic Biology Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Synthetic Biology Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Synthetic Biology Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Synthetic Biology Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Synthetic Biology Market: Competitive Structure
  • Table 7: Global: Synthetic Biology Market: Key Players